Breakthrough in Genetic Disease Treatment for UK Children

Scientists from Newcastle University announced on Wednesday that eight children in the UK have successfully overcome severe genetic diseases.

This groundbreaking technique, currently banned in the US, involves transferring genetic material from a mother’s fertilized egg, along with the father’s sperm nucleus, to healthy eggs from an anonymous donor.

Mutant genes found in the mother’s mitochondria can lead to serious, often fatal conditions. These mitochondria are crucial as they generate energy for various organs, especially those with high energy demands like the brain, heart, and muscles.

Among the eight children, one is two years old, two are between one and two, and five are infants. According to scientists, all of them were born healthy, and blood tests indicate low levels of mitochondrial gene mutations.

So far, their developmental progress is normal, which is, of course, promising.

The researchers highlighted that this achievement involves not just scientific innovation, but also ethical considerations, patient engagement, legislative processes, and ongoing monitoring to protect both mothers and infants. It’s been a long journey filled with dedicated work.

Greenfield expressed hope that the data collected could pave the way for future research advancements.

During the IVF procedure, doctors can identify healthier eggs with minimal mitochondrial mutations for potential use in transplantation. However, all mitochondrial DNA carries some mutations. Thus, British doctors initially fertilize the mother’s egg with the father’s sperm.

Afterward, they remove the “pronuclei” of the fertilized egg—these are essential for development and contain genetic information from both parents. The nuclei are then transferred to donated eggs that have had their pronuclei removed, allowing healthy mitrochondria and nuclear DNA to thrive.

This innovative method was described in a second paper published in a scientific journal. Mary Herbert, a senior researcher, noted at a press event, “We’re replacing unhealthy mitochondrial DNA with healthy donor mtDNA.”

The results were significant; mutations in mitochondrial DNA were found to be 95% to 100% lower in six newborns, and 77% to 88% lower in the other two, compared to their mother’s levels.

This method effectively curtails the transmission of mitochondrial diseases, the scientists explained.

The procedure was tested on 22 women at risk of passing on these genetic conditions. In addition to the eight who successfully gave birth, another one of the 22 is currently pregnant. Seven of the pregnancies are proceeding without complications, though one mother did have elevated lipid levels in blood tests.

Importantly, there were no miscarriages reported.

While the current study also explored implanting the mother’s unfertilized nuclei into donor eggs, the team believes their new approach is more reliable in preventing genetic disorders.

In 2015, the UK became the first country to permit research into human mitochondrial donation treatments. In sharp contrast, the US essentially outlawed nuclear transfers through a Congressional Budget Bill, halting any potential consideration for “genetic modifications.”